Cargando…

Current options and future directions of systemic therapy for advanced biliary tract cancer

Biliary tract cancers (BTCs) are aggressive tumors arising from different portions of the biliary tree and classified according to the anatomical location in intrahepatic (i) cholangiocarcinoma (CCA, iCCA), perihilar CCA (pCCA), and distal CCA (dCCA), gallbladder cancer (GBC), and ampulla of Vater c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Prete, Maria Giuseppina, Cammarota, Antonella, D’Alessio, Antonio, Zanuso, Valentina, Rimassa, Lorenza
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Open Exploration 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9400707/ https://www.ncbi.nlm.nih.gov/pubmed/36045701 http://dx.doi.org/10.37349/etat.2021.00054

Ejemplares similares

The Role of Cabozantinib as a Therapeutic Option for Hepatocellular Carcinoma: Current Landscape and Future Challenges
por: D’Alessio, Antonio, et al.
Publicado: (2021)

Assessment and Monitoring of Response to Systemic Treatment in Advanced Hepatocellular Carcinoma: Current Insights
por: Cammarota, Antonella, et al.
Publicado: (2022)

PD-1 Blockade for Hepatocellular Carcinoma: Current Research and Future Prospects
por: D’Alessio, Antonio, et al.
Publicado: (2021)

Immunotherapy in hepatocellular carcinoma: how will it reshape treatment sequencing?
por: Cammarota, Antonella, et al.
Publicado: (2023)

Biliary Tract Cancers: Molecular Heterogeneity and New Treatment Options
por: Personeni, Nicola, et al.
Publicado: (2020)

Safety and Efficacy of Atezolizumab and Bevacizumab Combination as a First Line Treatment of Advanced Hepatocellular Carcinoma
por: Zanuso, Valentina, et al.
Publicado: (2023)

Implementing Pre-Therapeutic UGT1A1 Genotyping in Clinical Practice: A Real-Life Study
por: Personeni, Nicola, et al.
Publicado: (2022)

Systemic treatment options for advanced biliary tract carcinoma
por: Xie, Changqing, et al.
Publicado: (2020)

Pancreatic Ductal Adenocarcinoma and Immune Checkpoint Inhibitors: The Gray Curtain of Immunotherapy and Spikes of Lights
por: Balsano, Rita, et al.
Publicado: (2023)

Determinants of Treatment Benefit and Post-Treatment Survival for Patients with Hepatocellular Carcinoma Enrolled in Second-Line Trials after the Failure of Sorafenib Treatment
por: Personeni, Nicola, et al.
Publicado: (2022)

Biliary tract cancer: current challenges and future prospects
por: Ghidini, Michele, et al.
Publicado: (2018)

Tackling Refractory Metastatic Colorectal Cancer: Future Perspectives
por: Personeni, Nicola, et al.
Publicado: (2021)

Targeting Angiogenesis in Biliary Tract Cancers: An Open Option
por: Simone, Valeria, et al.
Publicado: (2017)

Immunotherapy in biliary tract cancers: Current evidence and future perspectives
por: Uson Junior, Pedro Luiz Serrano, et al.
Publicado: (2022)

ALBI grade: Evidence for an improved model for liver functional estimation in patients with hepatocellular carcinoma
por: Demirtas, Coskun O., et al.
Publicado: (2021)

New and emerging treatment options for biliary tract cancer
por: Noel, Marcus S, et al.
Publicado: (2013)

Biliary tract cancers: current knowledge, clinical candidates and future challenges
por: Tariq, Noor-ul-Ain, et al.
Publicado: (2019)

Current status of chemotherapy for the treatment of advanced biliary tract cancer
por: Sasaki, Takashi, et al.
Publicado: (2013)

Which choice of therapy when many are available? Current systemic therapies for advanced hepatocellular carcinoma
por: Personeni, Nicola, et al.
Publicado: (2020)

Current Options and Future Directions in Immune Therapy for Glioblastoma
por: Lynes, John, et al.
Publicado: (2018)

Current Options and Future Directions for NAFLD and NASH Treatment
por: Zhang, Chunye, et al.
Publicado: (2021)

Current Progress and Future Perspectives of Immune Checkpoint Inhibitors in Biliary Tract Cancer
por: Seesaha, Poshita-Kumari, et al.
Publicado: (2021)

Biliary tract cancer stem cells - translational options and challenges
por: Mayr, Christian, et al.
Publicado: (2017)

Characterisation of the immune-related transcriptome in resected biliary tract cancers
por: Ghidini, Michele, et al.
Publicado: (2017)

Targeting BRAF-Mutant Biliary Tract Cancer: Recent Advances and Future Challenges
por: Rizzo, Alessandro, et al.
Publicado: (2020)

Immunotherapy for Biliary Tract Cancer in the Era of Precision Medicine: Current Knowledge and Future Perspectives
por: Ciardiello, Davide, et al.
Publicado: (2022)

Current Role and Future Perspectives of Immunotherapy and Circulating Factors in Treatment of Biliary Tract Cancers
por: Conci, Simone, et al.
Publicado: (2023)

Immunotherapy in Advanced Biliary Tract Cancers
por: Boilève, Alice, et al.
Publicado: (2021)

Toripalimab in advanced biliary tract cancer
por: Li, Wei, et al.
Publicado: (2022)

Hepatotoxicity in Patients with Hepatocellular Carcinoma on Treatment with Immune Checkpoint Inhibitors
por: Personeni, Nicola, et al.
Publicado: (2021)

Management of early rectal cancer; current surgical options and future direction
por: Chavda, Vijay, et al.
Publicado: (2021)

Biliary Tract Cancers: Treatment Updates and Future Directions in the Era of Precision Medicine and Immuno-Oncology
por: Manne, Ashish, et al.
Publicado: (2021)

Dual HER2 Blockade: An Emerging Option in Metastatic Biliary Tract Cancer?
por: Ricci, Angela Dalia, et al.
Publicado: (2021)

Combination Therapies for Advanced Biliary Tract Cancer
por: Zeng, Weifeng, et al.
Publicado: (2023)

Current Status and Future Perspectives of Perioperative Therapy for Resectable Biliary Tract Cancer: A Multidisciplinary Review
por: Yoo, Changhoon, et al.
Publicado: (2021)

Liquid biopsy in biliary tract cancer from blood and bile samples: current knowledge and future perspectives
por: Arrichiello, Gianluca, et al.
Publicado: (2022)

Biliary Tract Cancer: Current Medical Treatment Strategies
por: Oneda, Ester, et al.
Publicado: (2020)

Current progress in perioperative chemotherapy for biliary tract cancer
por: Ioka, Tatsuya, et al.
Publicado: (2023)

Management options for pediatric patients who stutter: current challenges and future directions
por: Donaghy, Michelle A, et al.
Publicado: (2016)

Treatment of systemic sclerosis associated fibrotic manifestations: Current options and future directions
por: Daoussis, Dimitrios, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_c9ns49os08g7rpb79q4ptjdqus